HomeProductsBioactive CompoundsAnti-Infective AgentsAntibacterial AgentsProdigiosin
Chemical structure of CAS 82-89-3

Prodigiosin

In Stock•Starting at $336 for 1 mg•Purity ≥ 98%
CAS No.82-89-3
MDL No.N/A
MFC20H25N3O
MW323.40
InChI KeySHUNBVWMKSXXOM-XDHOZWIPSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98+%$336In Stock
5 mg98+%$856In Stock
10 mg98+%$1368In Stock
25 mg98+%$2733In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.82-89-3
Product NameProdigiosin
Heavy Atom Count24Rotatable Bond Count7
Atom Stereo Count0Bond Stereo Count1
HBA2HBD2
TPSA53.170 ŲCharge0
Exact Mass323.19976Complexity775.92
pKa5.875XLogP4.758

Related Articles

Studies related to this compound and its mechanism of action

Neuroprotective efficacy of the bacterial metabolite, prodigiosin, against aluminium chloride-induced neurochemical alternations associated with Alzheimer's disease murine model: Involvement of Nrf2/HO-1/NF-κB signaling.

Environmental toxicology • Vol. 38, Issue 2 • 2023
PMID: 36447373DOI: 10.1002/tox.23718

Prodigiosin induces apoptosis and inhibits autophagy via the extracellular signal-regulated kinase pathway in K562 cells.

Toxicology in vitro : an international journal published in association with BIBRA • Vol. 60 • 2019
PMID: 31077745DOI: 10.1016/j.tiv.2019.05.003

Prodigiosin-induced cytotoxicity involves RAD51 down-regulation through the JNK and p38 MAPK pathways in human breast carcinoma cell lines.

Toxicology letters • Vol. 212, Issue 1 • 2012
PMID: 22579953DOI: 10.1016/j.toxlet.2012.05.002

Prodigiosin inhibits gp91(phox) and iNOS expression to protect mice against the oxidative/nitrosative brain injury induced by hypoxia-ischemia.

Toxicology and applied pharmacology • Vol. 257, Issue 1 • 2011
PMID: 21925195DOI: 10.1016/j.taap.2011.08.027

Documentation

Similar Products